A billion dollars isn’t what it used to be
Executive Summary
Pfizer reduces revenue guidance for full year from $54 bil. to $52.5-$53 bil. The change reflects "revisions for a number of products as well as the effect of foreign exchange fluctuations," Pfizer said. Nevertheless, the company reaffirmed full year earnings guidance of $2.13 per share...